340B Analytics

340B Analytics

Self-Police Revenue Leakage due to 340B Program Non-Compliance

Since 2015, the 340B program has grown explosively. The number of new covered entity sites increased by more than 16,000 locations, and registered contract pharmacies have ballooned by 31,188. Paralleling the overall market trend, there are now over 10,000 specialty pharmacies acting as contract pharmacies.

While 340B sales represents only about 6% of total pharmaceutical sales overall, the mix of 340B business is well over 50% of sales for Oncology, Immunology, and other specialty therapies. The 340B influence is a major factor in the escalation in list prices for innovative drugs.

Your team needs data and analytics solutions to investigate instances of non-compliance, specifically diversion and duplicate discounting. Using our ICyte Platform to crosswalk pharmacy sell-in data, rebates, and chargebacks, your team can identify non-compliant 340B transactions.

Our 340B Analytics offers enriched 340B-focused visualizations including commercial and 340B transactions across every covered entity and covered entity site of care, including contract pharmacies.

Identify Suspected Diversion and Duplicate Discounts

  • Ingest and Match unblinded channel sales, ExFactory, returns, chargebacks and rebate claims data
  • Master Transactions against IntegriChain’s Outlet master data for Bill-To, Ship-To and Class of Trade alignment
  • Trend 340B Mix at the Covered Entity and Contract Pharmacy parent and site-of-care outlet level
  • Compare Rebate Units Dispensed (commercial, Part D and Medicaid) to 340B mix and Sell-In by outlet
  • Identify Diversion and Duplicate Discounts at covered entity and contract pharmacy levels
  • Deliver Pharmacy Exclusion Extract to external rebate scrubbing systems
adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article